Gossamer Bio, Inc. (GOSS) Profit Margins
Over the twelve months to 2026-06-30, Gossamer Bio, Inc. (GOSS) had operating margin -311.7%, net margin -235.0%, free cash flow margin -305.2%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
GOSSGossamer Bio, Inc.Follow GOSS — free
—
Price chart with a free account
- Market cap
- 4.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|
| Operating margin | -52.2% | -352.2% | -311.7% | |
| Net margin | -49.3% | -351.5% | -235.0% | |
| FCF margin | -3.0% | -353.5% | -305.2% |
USD millions · SEC XBRL
Gossamer Bio, Inc. — questions
- What is Gossamer Bio, Inc.'s operating margin?
- -311.7% over the twelve months to 2026-06-30.
- What is Gossamer Bio, Inc.'s net profit margin?
- -235.0% over the twelve months to 2026-06-30.
Every figure on this page comes from Gossamer Bio, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.